December 1, 2022

Volume XII, Number 335

David S. Ivill

David S. Ivill is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s New York office.  He is the partner-in-charge of the Health Industry Advisory practice in New York.  David has extensive experience in statutory and regulatory issues affecting the provision of health care services, particularly with respect to New York State; his practice includes counseling with respect to operational and management issues, fraud and abuse, Medicaid Managed Care, compliance programs, as well as reimbursement matters, corporate practice of medicine issues and not-for-profit/tax-exempt matters.  David also has significant experience working with federally qualified health centers and advising clients with respect to the 340B Federal Drug Pricing Program.  He represents a range of health care providers including hospitals, physicians and rehabilitation agencies, as well as other health care entities including clinical laboratories and medical device manufacturers.  David represents Patient Safety Organizations (PSO) and has developed some of the first PSOs in the country.  He also has private equity and mergers and acquisitions experience.

David is listed in Best Lawyers in America and has been recognized by Chambers USA as one of the leading lawyers in his field.  He is a member of the American Health Lawyers Association and the Bar of the City of New York.  

Prior to practicing law, David was a podiatric surgeon specializing in foot and ankle reconstruction with a subspecialty in oteomyelitis of the lower extremity.

Articles in the National Law Review database by David S. Ivill